Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Subcellular mobility of the calpain/calpastatin network: an organelle transient.

Hood JL, Brooks WH, Roszman TL.

Bioessays. 2006 Aug;28(8):850-9. Review.

PMID:
16927317
2.

Tubulin polymerization modulates interleukin-2 receptor signal transduction in human T cells.

Goebel J, Forrest K, Wills-Karp M, Roszman TL.

J Recept Signal Transduct Res. 2006;26(1-2):87-106.

PMID:
16595340
3.

Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain.

Goebel J, Logan B, Forrest K, Mieczkowski A, Roszman TL, Wills-Karp M.

J Investig Med. 2005 Sep;53(6):322-8. doi: 10.2310/6650.2005.53610.

PMID:
16207471
4.

Daclizumab therapy in kidney transplantation-different mechanisms of action in- versus ex-vivo?

Forrest K, Logan B, Strange J, Roszman TL, Goebel J.

Transpl Immunol. 2005 Mar;14(1):43-7. Epub 2005 Jan 4.

PMID:
15814281
5.

Differential compartmentalization of the calpain/calpastatin network with the endoplasmic reticulum and Golgi apparatus.

Hood JL, Brooks WH, Roszman TL.

J Biol Chem. 2004 Oct 8;279(41):43126-35. Epub 2004 Aug 9.

6.

Lipid rafts in cytokine signaling.

Rao R, Logan B, Forrest K, Roszman TL, Goebel J.

Cytokine Growth Factor Rev. 2004 Apr-Jun;15(2-3):103-10. Review.

PMID:
15110794
7.

Association of the calpain/calpastatin network with subcellular organelles.

Hood JL, Logan BB, Sinai AP, Brooks WH, Roszman TL.

Biochem Biophys Res Commun. 2003 Oct 31;310(4):1200-12.

PMID:
14559243
8.

Lipid rafts, major histocompatibility complex molecules, and immune regulation.

Goebel J, Forrest K, Flynn D, Rao R, Roszman TL.

Hum Immunol. 2002 Oct;63(10):813-20.

PMID:
12368033
9.

Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells.

Morford LA, Forrest K, Logan B, Overstreet LK, Goebel J, Brooks WH, Roszman TL.

Biochem Biophys Res Commun. 2002 Jul 12;295(2):540-6.

PMID:
12150984
10.

Differential localization of IL-2- and -15 receptor chains in membrane rafts of human T cells.

Goebel J, Forrest K, Morford L, Roszman TL.

J Leukoc Biol. 2002 Jul;72(1):199-206.

PMID:
12101281
11.

Daclizumab (Zenapax) inhibits early interleukin-2 receptor signal transduction events.

Goebel J, Stevens E, Forrest K, Roszman TL.

Transpl Immunol. 2000 Nov;8(3):153-9.

PMID:
11147695
12.

Beta1 integrin-mediated T cell adhesion and cell spreading are regulated by calpain.

Rock MT, Dix AR, Brooks WH, Roszman TL.

Exp Cell Res. 2000 Nov 25;261(1):260-70.

PMID:
11082296
13.

Immune defects observed in patients with primary malignant brain tumors.

Dix AR, Brooks WH, Roszman TL, Morford LA.

J Neuroimmunol. 1999 Dec;100(1-2):216-32. Review.

PMID:
10695732
14.

Apoptotic elimination of peripheral T lymphocytes in patients with primary intracranial tumors.

Morford LA, Dix AR, Brooks WH, Roszman TL.

J Neurosurg. 1999 Dec;91(6):935-46.

PMID:
10584838
15.

Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.

Zou JP, Morford LA, Chougnet C, Dix AR, Brooks AG, Torres N, Shuman JD, Coligan JE, Brooks WH, Roszman TL, Shearer GM.

J Immunol. 1999 Apr 15;162(8):4882-92.

17.

T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors.

Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL.

J Immunol. 1997 Nov 1;159(9):4415-25.

PMID:
9379040
18.

Insulin-like growth factors (IGF) enhance three-dimensional (3D) growth of human glioblastomas.

Morford LA, Boghaert ER, Brooks WH, Roszman TL.

Cancer Lett. 1997 May 1;115(1):81-90.

PMID:
9097982
19.

Interactive signaling pathways of the neuroendocrine-immune network.

Roszman TL, Brooks WH.

Chem Immunol. 1997;69:203-22. Review. No abstract available.

PMID:
9353967
20.

Proteolytic cleavage of alpha-actinin by calpain in T cells stimulated with anti-CD3 monoclonal antibody.

Selliah N, Brooks WH, Roszman TL.

J Immunol. 1996 May 1;156(9):3215-21.

PMID:
8617943
21.

Dexamethasone and prostaglandin E2 modulate T-cell receptor signaling through a cAMP-independent mechanism.

Elliott LH, Levay AK, Sparks B, Miller M, Roszman TL.

Cell Immunol. 1996 Apr 10;169(1):117-24.

PMID:
8612284
22.

Functional characterization of the insulin-like growth factor I receptor on Jurkat T cells.

Cross RJ, Elliott LH, Morford LA, Roszman TL, McGillis JP.

Cell Immunol. 1995 Feb;160(2):205-10.

PMID:
7720081
23.

cAMP accumulation in T-cells inhibits anti-CD3 monoclonal antibody-induced actin polymerization.

Selliah N, Bartik MM, Carlson SL, Brooks WH, Roszman TL.

J Neuroimmunol. 1995 Jan;56(1):107-12.

PMID:
7822476
25.

Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.

Bartik MM, Bauman GP, Brooks WH, Roszman TL.

Cell Immunol. 1994 Oct 1;158(1):116-30.

PMID:
8087859
26.

Enhancement of beta-adrenergic-induced cAMP accumulation in activated T-cells.

Carlson SL, Trauth K, Brooks WH, Roszman TL.

J Cell Physiol. 1994 Oct;161(1):39-48.

PMID:
7929606
28.

Proliferative potential of T-cell lymphocytes from gliomas.

Roszman TL, Elliott LH, Brooks WH.

J Neurosurg. 1992 Nov;77(5):820-1. No abstract available.

PMID:
1403131
29.
30.

Immunologic disparity in the hypopituitary dwarf mouse.

Cross RJ, Bryson JS, Roszman TL.

J Immunol. 1992 Mar 1;148(5):1347-52.

PMID:
1531667
31.

Signaling pathways of the neuroendocrine-immune network.

Roszman TL, Brooks WH.

Chem Immunol. 1992;52:170-90. Review. No abstract available.

PMID:
1348941
32.

Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice.

Cross RJ, Campbell JL, Markesbery WR, Roszman TL.

Mech Ageing Dev. 1990 Oct;56(1):11-22.

PMID:
2259251
34.

Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland.

Cross RJ, Campbell JL, Roszman TL.

J Neuroimmunol. 1989 Nov;25(1):29-35.

PMID:
2584390
35.

Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production.

Carlson SL, Brooks WH, Roszman TL.

J Neuroimmunol. 1989 Sep;24(1-2):155-62.

PMID:
2572605
36.

Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation.

Cross RJ, Roszman TL.

J Neuroimmunol. 1988 Aug;19(1-2):33-45.

PMID:
3260905
37.

Signaling pathways of the neuroendocrine-immune network.

Roszman TL, Brooks WH.

Prog Allergy. 1988;43:140-59. Review. No abstract available.

PMID:
3059357
38.

Specific uptake of serotonin by murine macrophages.

Jackson JC, Walker RF, Brooks WH, Roszman TL.

Life Sci. 1988;42(17):1641-50.

PMID:
2452944
39.

Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor.

Roszman TL, Brooks WH, Elliott LH.

J Neurosurg. 1987 Dec;67(6):874-9.

PMID:
2824719
40.

Activation of immunoregulatory lymphocytes obtained from patients with malignant gliomas.

Elliott LH, Brooks WH, Roszman TL.

J Neurosurg. 1987 Aug;67(2):231-6.

PMID:
2885402
41.

Modulation of T-suppressor cell activity by central nervous system catecholamine depletion.

Cross RJ, Brooks WH, Roszman TL.

J Neurosci Res. 1987;18(1):75-81.

PMID:
2960825
42.

Booster effect in delayed hypersensitivity skin testing.

Maguire LC, Lackey SD, Roszman TL, Kidwell NS.

South Med J. 1986 Sep;79(9):1080-1.

PMID:
3749990
43.

Some parameters of conditioned immunosuppression: species difference and CS-US delay.

McCoy DF, Roszman TL, Miller JS, Kelly KS, Titus MJ.

Physiol Behav. 1986;36(4):731-6.

PMID:
3520612
44.

Neuroimmunomodulation: impairment of humoral immune responsiveness by 6-hydroxydopamine treatment.

Cross RJ, Jackson JC, Brooks WH, Sparks DL, Markesbery WR, Roszman TL.

Immunology. 1986 Jan;57(1):145-52.

45.

Neural modulation of immune function.

Roszman TL, Brooks WH.

J Neuroimmunol. 1985 Nov;10(1):59-69. Review.

PMID:
3932461
46.

Failure of cimetidine as an immunomodulator in cancer patients and normal subjects.

Maguire LC, Roszman TL, Lackey S.

South Med J. 1985 Sep;78(9):1078-80.

PMID:
4035435
47.

Neuroanatomic and neurotransmitter influences on immune function.

Roszman TL, Jackson JC, Cross RJ, Titus MJ, Markesbery WR, Brooks WH.

J Immunol. 1985 Aug;135(2 Suppl):769s-772s. No abstract available.

PMID:
2861232
48.

Influence of serotonin on the immune response.

Jackson JC, Cross RJ, Walker RF, Markesbery WR, Brooks WH, Roszman TL.

Immunology. 1985 Mar;54(3):505-12.

50.

Supplemental Content

Loading ...
Support Center